XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended 12 Months Ended
Jun. 30, 2020
Sep. 30, 2019
Operating Activities    
Net loss $ (13,318,408) $ (12,625,204)
Adjustments to reconcile net loss to net cash used in operating activities:    
Accretion expense 3,971,342 2,241,933
Change in fair value of derivative liability 5,863,127 218,922
Discount on convertible notes payable 396,893 198,602
Fair value of share purchase warrants, Value 179,077 0
Shares issued for mineral property exploration costs (1,319,326) (571,962)
Shares issued for services 1,072,378 7,093,110
Changes in operating assets and liabilities:    
Prepaid expenses (182,935) 135,927
Accounts payable and accrued liabilities 152,653 199,813
Due to related parties 166,680 (124,608)
Net Cash Used in Operating Activities (3,018,519) (3,233,467)
Investing Activities    
Acquisition of equipment (3,896) 0
Net Cash Used in Investing Activities (3,896) 0
Financing Activities    
Proceeds from issuance of convertible notes payable 2,522,250 4,601,900
Proceeds from bank loan 255,992 0
Repayment of convertible note payable (1,533,274) (1,483,831)
Proceeds from share subscriptions received 2,600,000 0
Net Cash Provided by Financing Activities 3,844,968 3,118,069
Change in Cash 822,553 (115,398)
Cash and Cash Equivalents, at Carrying Value, Beginning Balance 7,371 122,769
Cash and Cash Equivalents, at Carrying Value, Ending Balance 829,924 7,371
Supplemental disclosures:    
Interest paid 64,973 0
Income taxes paid 0 0
Non-cash investing and financing activities:    
Discount on convertible debenture 396,893 198,602
Original issue discount on convertible debentures 149,300 99,750
Preferred shares issued to officers and directors 300 0
Common shares issued to settle accrued interest 0 123,795
Common shares issued for joint venture 0 35,250
Common shares issued for conversion of debt $ 9,313,911 $ 3,018,099